Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morel-Kopp, M.-C.
Right arrow Articles by Kieffer, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morel-Kopp, M.-C.
Right arrow Articles by Kieffer, N.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

A Three Amino Acid Deletion in Glycoprotein IIIa Is Responsible for Type I Glanzmann's Thrombasthenia: Importance of Residues Ile325Pro326Gly327 for beta 3 Integrin Subunit Association

Marie-Christine Morel-Kopp, Cécile Kaplan, Valérie Proulle, Vincent Jallu, Chantal Melchior, Olivier Peyruchaud, Marie-Hélène Aurousseau, and Nelly Kieffer

From the Service d'Immunologie Leucoplaquettaire, GIP-INTS, Paris, France; UMR 5533 CNRS, Hôpital Cardiologique, Pessac, France; the Laboratoire d'Hématologie, Hôpital Jean Verdier, Bondy, France; and the Laboratoire Franco-Luxembourgeois de Recherche Biomédicale, Centre Universitaire, Luxembourg.

Glanzmann's thrombasthenia (GT) is a recessive autosomal bleeding disorder characterized by abnormal platelet aggregation due to a qualitative or quantitative defect of the glycoprotein (GP) IIb-IIIa complex (integrin alpha IIbbeta 3). We describe a new mutation in the GPIIIa gene responsible for type I GT in a consanguineous Algerian family. A discordance between phenotyping and genotyping of the GPIIIa-related HPA-1 platelet alloantigen system in three family members heterozygous for the disease suggested a genetic defect in the GPIIIa gene and a normal GPIIb gene. Sequence analysis of amplified genomic DNA fragments showed a 6-bp deletion in exon 7 of the GPIIIa gene resulting in the amino acid deletion/substitution (Ile325Pro326Gly327 right-arrow Met) and creating a new BspHI restriction site. Expression of the mutated integrin beta 3 subunit cDNA in Chinese hamster ovary cells showed that the cDNA gene was transcribed into a full-length beta 3 protein with an apparent molecular weight identical to wild-type beta 3 and accumulated as a single-chain molecule in the cell cytoplasm. The absence of heterodimeric complex formation of the mutant beta 3 protein with endogeneous alpha v was shown by immunoprecipitation experiments, intracellular immunofluorescent labeling, and a semiquantitative enzyme-linked immunosorbent assay using the alpha vbeta 3 complex-specific monoclonal antibodies LM609 and 23C6. Substitution of the methionine residue by a proline, present at position 326 of wild-type beta 3, did not restore the ability of the recombinant mutant beta 3 protein to associate with alpha v, suggesting that the Ile-Pro-Gly motif is located in a beta 3 domain important for integrin subunit interaction. The association of a BspHI restriction site with this newly identified mutation has allowed allele-specific restriction analysis of Algerian GT individuals and the identification of two new unrelated type I patients exhibiting the same mutation, suggesting that the described mutation might be significant in this population and that BspHI restriction analysis will provide a useful screening assay for antenatal diagnosis and genetic counselling.

Blood, Vol. 90 No. 2 (July 15), 1997: pp. 669-677
© 1997 by The American Society of Hematology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
M. Kannan and R. Saxena
Glanzmann's Thrombasthenia: An Overview
Clinical and Applied Thrombosis/Hemostasis, April 1, 2009; 15(2): 152 - 165.
[Abstract] [PDF]


Home page
BloodHome page
N. Rosenberg, R. Yatuv, V. Sobolev, H. Peretz, A. Zivelin, and U. Seligsohn
Major mutations in calf-1 and calf-2 domains of glycoprotein IIb in patients with Glanzmann thrombasthenia enable GPIIb/IIIa complex formation, but impair its transport from the endoplasmic reticulum to the Golgi apparatus
Blood, June 15, 2003; 101(12): 4808 - 4815.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Hermand, P. Gane, M. Huet, V. Jallu, C. Kaplan, H. H. Sonneborn, J.-P. Cartron, and P. Bailly
Red Cell ICAM-4 Is a Novel Ligand for Platelet-activated alpha IIbbeta 3 Integrin
J. Biol. Chem., February 7, 2003; 278(7): 4892 - 4898.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Yatuv, N. Rosenberg, A. Zivelin, H. Peretz, R. Dardik, L. Trakhtenbrot, and U. Seligsohn
Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: further lessons from Iraqi-Jewish Glanzmann thrombasthenia
Blood, August 15, 2001; 98(4): 1063 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
M. K. Boudreaux and D. L. Lipscomb
Clinical, Biochemical, and Molecular Aspects of Glanzmann's Thrombasthenia in Humans and Dogs
Vet. Pathol., May 1, 2001; 38(3): 249 - 260.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
D Inwald, E G Davies, and N Klein
Demystified ...: Adhesion molecule deficiencies
Mol. Pathol., February 1, 2001; 54(1): 1 - 7.
[Abstract] [Full Text]


Home page
Vet PatholHome page
D. L. Lipscomb, C. Bourne, and M. K. Boudreaux
Two Genetic Defects in {alpha}IIb Are Associated with Type I Glanzmann's Thrombasthenia in a Great Pyrenees Dog: A 14-base Insertion in Exon 13 and a Splicing Defect of Intron 13
Vet. Pathol., November 1, 2000; 37(6): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Gonzalez-Manchon, M. Fernandez-Pinel, E. G. Arias-Salgado, M. Ferrer, M.-V. Alvarez, S. Garcia-Munoz, M. S. Ayuso, and R. Parrilla
Molecular Genetic Analysis of a Compound Heterozygote for the Glycoprotein (GP) IIb Gene Associated With Glanzmann's Thrombasthenia: Disruption of the 674-687 Disulfide Bridge in GPIIb Prevents Surface Exposure of GPIIb-IIIa Complexes
Blood, February 1, 1999; 93(3): 866 - 875.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Peyruchaud, A.T. Nurden, S. Milet, L. Macchi, A. Pannochia, P.F. Bray, N. Kieffer, and F. Bourre
R to Q Amino Acid Substitution in the GFFKR Sequence of the Cytoplasmic Domain of the Integrin alpha IIb Subunit in a Patient With a Glanzmann's Thrombasthenia-Like Syndrome
Blood, December 1, 1998; 92(11): 4178 - 4187.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. M. Grimaldi, F. Chen, C. Wu, H. J. Weiss, B. S. Coller, and D. L. French
Glycoprotein IIb Leu214Pro Mutation Produces Glanzmann Thrombasthenia With Both Quantitative and Qualitative Abnormalities in GPIIb/IIIa
Blood, March 1, 1998; 91(5): 1562 - 1571.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1997 by American Society of Hematology         Online ISSN: 1528-0020